巨噬细胞移动抑制因子调控U1小核核糖核蛋白免疫复合物介导的NLRP3炎症小体活化
本研究探讨U1小核核糖核蛋白(snRNP)免疫复合物上调人单核细胞巨噬细胞移动抑制因子(MIF)表达及其与NLRP3炎症小体相互作用。结果显示snRNP免疫复合物诱导单核细胞产生MIF和IL-1β,MIF调控NLRP3炎症小体活化;MIF098抑制MIF与受体结合后减少IL-1β产生、NLRP3上调和caspase 1活化。
要点
- U1 snRNP免疫复合物可刺激人单核细胞产生MIF和IL-1β。
- MIF通过调控NLRP3炎症小体活化影响单核细胞炎症特征。
- MIF098阻断MIF与受体结合后抑制IL-1β产生及caspase 1活化。
核心结论
- U1 snRNP免疫复合物是人单核细胞产生MIF的特异性刺激物,MIF通过调控NLRP3炎症小体活化及下游IL-1β产生,在上游决定活化单核细胞的炎症特征。
- 这些发现为在特定狼疮患者亚组(如高基因型MIF表达者或抗snRNP抗体阳性者)中靶向MIF提供了机制见解和治疗依据。
研究设计与样本
- 研究用人单核细胞与或不与snRNP免疫复合物共孵育,采用酶联免疫吸附试验、Western印迹、定量聚合酶链反应和飞行时间质谱流式细胞术(CytoF)分析MIF、IL-1β、NLRP3、caspase 1、ASC和MIF受体。
- 用新型小分子拮抗剂MIF098探查MIF通路反应。
主要发现
- snRNP免疫复合物诱导人单核细胞产生MIF和IL-1β。
- 高维单细胞CytoF分析确定MIF调控NLRP3炎症小体活化,包括发现单核细胞中MIF及其受体与IL-1β水平之间存在定量关系。
- MIF098阻断MIF与其同源受体结合,抑制snRNP免疫复合物刺激的人单核细胞中IL-1β产生、NLRP3上调(NLRP3炎症小体活化的限速步骤)和caspase 1活化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: High-expression alleles of macrophage migration inhibitory factor (MIF) are linked genetically to the severity of systemic lupus erythematosus (SLE). The U1 small nuclear RNP (snRNP) immune complex containing U1 snRNP and anti-U1 snRNP antibodies, which are found in patients with SLE, activates the NLRP3 inflammasome, comprising NLRP3, ASC, and procaspase 1, in human monocytes, leading to the production of interleukin-1β (IL-1β). This study was undertaken to investigate the role of the snRNP immune complex in up-regulating the expression of MIF and its interface with the NLRP3 inflammasome. METHODS: MIF, IL-1β, NLRP3, caspase 1, ASC, and MIF receptors were analyzed by enzyme-linked immunosorbent assay, Western blotting, quantitative polymerase chain reaction, and cytometry by time-of-flight mass spectrometry (CytoF) in human monocytes incubated with or without the snRNP immune complex. MIF pathway responses were probed with the novel small molecule antagonist MIF098. RESULTS: The snRNP immune complex induced the production of MIF and IL-1β from human monocytes. High-dimensional, single-cell CytoF analysis established that MIF regulates activation of the NLRP3 inflammasome, including findings of a quantitative relationship between MIF and its receptors and IL-1β levels in the monocytes. MIF098, which blocks MIF binding to its cognate receptor, suppressed the production of IL-1β, the up-regulation of NLRP3, which is a rate-limiting step in NLRP3 inflammasome activation, and the activation of caspase 1 in snRNP immune complex-stimulated human monocytes. CONCLUSION: The U1 snRNP immune complex is a specific stimulus of MIF production in human monocytes, with MIF having an upstream role in defining the inflammatory characteristics of activated monocytes by regulating NLRP3 inflammasome activation and downstream IL-1β production. These findings provide mechanistic insight and a therapeutic rationale for targeting MIF in subgroups of lupus patients, such as those classified as high genotypic MIF expressers or those with anti-snRNP antibodies.
引用
- Shin MS, Kang Y, Wahl ER, et al. Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome. Arthritis Rheumatol. 2018. PMID: 30009530. doi:10.1002/art.40672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。